Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world data.
Karine RonanEmmet JordanChristine LeonardRay McDermottPublished in: Irish journal of medical science (2023)
This study provides an understanding of the use of NGS and prevalence of genomic alterations in an Irish patient population.